A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation

Jiang Tian, Qinyao Xu, Zexin Wang, Zeyu Wang, Haofang Zhu, Lingyun Sun, Zhongwei Gu

Open source

DOI
10.7150/thno.136356
Published
2026-09-03
Container
Theranostics
Publisher
Ivyspring International Publisher
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7150/thno.136356,
  title = {A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation},
  author = {Jiang Tian and Qinyao Xu and Zexin Wang and Zeyu Wang and Haofang Zhu and Lingyun Sun and Zhongwei Gu},
  year = {2026},
  journal = {Theranostics},
  doi = {10.7150/thno.136356},
  url = {https://doi.org/10.7150/thno.136356}
}

RIS

TY  - JOUR
TI  - A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation
AU  - Jiang Tian
AU  - Qinyao Xu
AU  - Zexin Wang
AU  - Zeyu Wang
AU  - Haofang Zhu
AU  - Lingyun Sun
AU  - Zhongwei Gu
PY  - 2026
JO  - Theranostics
DO  - 10.7150/thno.136356
UR  - https://doi.org/10.7150/thno.136356
ER  - 

APA

Tian, J., Xu, Q., Wang, Z., Wang, Z., Zhu, H., Sun, L., & Gu, Z. (2026). A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation. Theranostics. https://doi.org/10.7150/thno.136356

Source records